Alexander Green, DPM
Podiatrist · Oak Ridge, TNNPI 1336638238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 68.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $450 and has fallen 67.3% since, to $147 in 2025.
Across 36 payments — averaging $31.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$778
- Stryker$124
- Treace Medical Concepts, Inc.$114
- Averitas Pharma Inc.$79
- Convatec Inc.$20
- Kowa Pharmaceuticals America, Inc.$15
- plus $12 from 1 others
What the payments were for
- Food & beverage$1,141100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 27 | $778 |
| Stryker | 1 | $124 |
| Treace Medical Concepts, Inc. | 1 | $114 |
| Averitas Pharma Inc. | 4 | $79 |
| Convatec Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$207
- Stravix$207
- STRAVIX PL$207
- STRAVIX MESH$207
- ALLOFIBER$124
- AUGMENT INJECTABLE$124
- TMC PSI CUT GUIDE SYSTEM$114
- Grafix$107
How this compares
$1,141 in reported general payments places this provider in the 60th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vancomycin Hcl | 12 | $3,141 |
| Ciclopirox | 65 | $1,648 |
| Colchicine | 17 | $558 |
| Doxycycline Monohydrate | 25 | $526 |
| Terbinafine Hcl | 44 | $344 |
| Doxycycline Hyclate | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Oak Ridge
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
- Christopher HendrixBartlett$13K
- Damieon BrownJasper$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.